Melanie Berman - NiSource VP Officer
| NOU Stock | EUR 35.40 0.40 1.12% |
Insider
Melanie Berman is VP Officer of NiSource
| Age | 52 |
| Phone | 877 647 5990 |
| Web | https://www.nisource.com |
Melanie Berman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Melanie Berman against NiSource stock is an integral part of due diligence when investing in NiSource. Melanie Berman insider activity provides valuable insight into whether NiSource is net buyers or sellers over its current business cycle. Note, NiSource insiders must abide by specific rules, including filing SEC forms every time they buy or sell NiSource'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Melanie Berman over six months ago Disposition of 3742 shares by Melanie Berman of NiSource at 27.963 subject to Rule 16b-3 |
NiSource Management Efficiency
The company has return on total asset (ROA) of 0.0292 % which means that it generated a profit of $0.0292 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1044 %, meaning that it generated $0.1044 on every $100 dollars invested by stockholders. NiSource's management efficiency ratios could be used to measure how well NiSource manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jean Filippi | Phibro Animal Health | N/A | |
| Artirat Charukitpipat | Bumrungrad Hospital Public | 55 | |
| E Corcoran | Phibro Animal Health | 72 | |
| Michel DVM | Siemens Healthineers AG | 62 | |
| Ramon Fuenmayor | Phibro Animal Health | N/A | |
| Daniel Kastner | Bumrungrad Hospital Public | N/A | |
| Andre Hartung | Siemens Healthineers AG | N/A | |
| Anthony Andolino | Phibro Animal Health | 50 | |
| Bernhard Montag | Siemens Healthineers AG | 54 | |
| David FACHE | Bumrungrad Hospital Public | N/A | |
| Jonathan Bendheim | Phibro Animal Health | 47 | |
| Christian Klaussner | Siemens Healthineers AG | N/A | |
| Jochen Schmitz | Siemens Healthineers AG | 57 | |
| Carsten Bertram | Siemens Healthineers AG | N/A | |
| Rob Aukerman | Phibro Animal Health | 65 | |
| Linda Lisahapanya | Bumrungrad Hospital Public | 70 | |
| Marc Koebernick | Siemens Healthineers AG | N/A | |
| Christopher Toth | Siemens Healthineers AG | 44 | |
| Tanee Maneenut | Bumrungrad Hospital Public | N/A | |
| Damian Finio | Phibro Animal Health | 53 | |
| Jeremy Ford | Bumrungrad Hospital Public | N/A | |
Management Performance
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0292 |
NiSource Leadership Team
Elected by the shareholders, the NiSource's board of directors comprises two types of representatives: NiSource inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NiSource. The board's role is to monitor NiSource's management team and ensure that shareholders' interests are well served. NiSource's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NiSource's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randy Hulen, VP Treasury | ||
| William Jefferson, Ex Officer | ||
| Donald Brown, Ex CFO | ||
| Shawn Anderson, VP Officer | ||
| Gunnar Gode, Chief VP | ||
| Charles Bankston, VP Officer | ||
| Lloyd Yates, CEO Pres | ||
| Christopher Garland, VP Officer | ||
| Melanie Berman, VP Officer | ||
| Kimberly Cuccia, Gen VP |
NiSource Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NiSource a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 22.42 B | |||
| Shares Outstanding | 412.51 M | |||
| Shares Owned By Insiders | 0.37 % | |||
| Shares Owned By Institutions | 94.68 % | |||
| Price To Earning | 80.83 X | |||
| Price To Book | 1.97 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in NiSource Stock
When determining whether NiSource offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NiSource's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nisource Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nisource Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NiSource. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in NiSource Stock please use our How to Invest in NiSource guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.